Chronic kidney disease, stage 3 (moderate)
ICD-10 Code: N18.3 · Body Part: Lumbar Spine
QME Evaluation Process
GFR assessment, urinalysis, imaging. Evaluate occupational toxic exposure or medication-related nephrotoxicity. Chapter 7 urinary system impairment.
Typical Impairment Rating
10-30% WPI
AMA Guides Edition
5th Edition
Common Treatments
Body Part Guide
Lumbar Spine Evaluation Guide
Impairment rating methods, common conditions, and QME evaluation protocols
QME Specialties for Chronic kidney disease, stage 3 (moderate)
Find a QME Specialist
Browse QME-certified physicians who evaluate chronic kidney disease, stage 3 (moderate) and related lumbar spine conditions in California.
Browse Neurology Physicians →Frequently Asked Questions
What is Chronic kidney disease, stage 3 (moderate) (N18.3)?
Chronic kidney disease, stage 3 (moderate) is an ICD-10 diagnosis code (N18.3) classified under Internal Medicine conditions. It affects the Lumbar Spine and is occasionally seen in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.
How is N18.3 rated for impairment?
The typical whole person impairment (WPI) range for Chronic kidney disease, stage 3 (moderate) is 10-30% WPI. The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.
What is the QME evaluation process for N18.3?
GFR assessment, urinalysis, imaging. Evaluate occupational toxic exposure or medication-related nephrotoxicity. Chapter 7 urinary system impairment.
What treatments are common for Chronic kidney disease, stage 3 (moderate)?
Common treatments for Chronic kidney disease, stage 3 (moderate) include ACE inhibitor/ARB, Dietary management, Monitoring, Nephrology referral. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.